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Aim of the work: The present work aimed at investigating infants (In neonatal 
and post neonatal period) and children suspected of having inborn errors of 
metabolism with unexplained mental retardation. The frequency pattern of 
the various amino acid disorders, in a group of selected infants and children 
was done to document the prevalence of various amino acid disorders among 
Egyptian children.
Patients and Method: In this study, recent methods to investigate such 
disorders have been carried out by amino acid analyzer which detects levels 
of amino acids. Extended metabolic screen which also detects amino acid 
disorders, organic acid disorders and the defects of fatty acid oxidation has 
been carried out. These recent methods have therefore the potential of yielding 
information on the physiological and pathophysiological status of different 
metabolic pathways, as well as their interrelationship.
Results: The total number of cases attending the outpatient clinic during the 
period of study were 1343 index cases, among them 50 index cases (3.72%) 
were suspected of having inborn errors of amino acid and, 20 cases (40%) 
of them have confirmed positive inborn errors of amino acid metabolism. 
Concerning the confirmed 20 cases, their ages ranged from 5 days to 11 years 
with a mean of 54.75±33.09 months with equally sex distribution. The overall 
consanguinity rate recorded was 65%, while the family history of the similarly 
affected cases was 30%. The main clinical findings included mental retardation 
85%, convulsions 40%, and hypo pigmentation 75%, micro-cephally 15%. 
Associated anomalies were present in 35% of cases. Among them eye anomalies 
were the most common (8%).
Conclusion: The prevalence of amino-acido-pathies during the period of the 
study was 1.5% (Of 20 studied cases), among them PKU was found to be the 
commonest amino-acido-pathies 1.11%, while the remaining diagnosed cases 
representing 0.07% for each. 
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INTRODUCTION:                                                                   
The inborn errors of amino acid 
metabolism are a family of genetic 
conditions in which an enzyme 
deficiency typically results in the toxic 
accumulation of substrates before the 
block, intermediates from alternative 
metabolic pathways, and defects in 
energy production and utilization caused 
by a deficiency of products beyond the 
block. Nearly every metabolic disease 
has several forms that vary in clinical 
severity and mode of inheritance.1
Mental retardation is a prominent 
finding of many hereditary metabolic 
diseases, but a fraction of mental 
retardation seen in daily practice is due 
to inborn errors of metabolism.2 Many 
patients are referred for evaluation of 
suspected inherited metabolic disorders. 
The common causes for such referrals 
are the presence of motormental 
retardation, multiple deaths of sibs due 
to unidentified cause, or other disease 
with suspected metabolic cause.3
The availability of early diagnosis 
and treatment is fundamental to the 
prevention of neurological damage in 
patients affected by metabolic disorders 
with neonatal expression.4
The aim of the present study was to 
evaluate the frequency of amino acid 
disorders in a suspected group of 
Egyptian infants and children with 
suggestive clinical picture, unexplained 
mental retardation, or positive family 
history of relative or sib deaths with 
consanguineous marriages.
SUBJECTS AND METHODS                                   
Subjects:
Subjects of the present study were 
selected from patients attending the out 
patient clinic of the Medical Genetic 
Center, Ain Shams University, for 
purposes of diagnosis, counseling and 
periodic follow up. During the period 
of study, the total number of cases 
attending the out patient clinic was 
1343 cases.
The present work comprised 50 index 
cases belonging to 46 families fulfilling 
the inclusion criteria, 23 males ranging 
in age from 9 months to 10 years (Mean 
43.87±26.65 months) and 27 females 




Lethargy, poor feeding, convulsions, 1. 
vomiting, coma.
Clinical deterioration in a previously 2. 
healthy neonate.
Positive family history of sibs 3. 
or other relative deaths with 
consanguineous marriage.
Children presented with:
Unexplained mental retardation, 1. 
developmental delay or 
convulsions.
Intermittent episodes of unexplained 2. 
vomiting, acidosis, mental 
retardation or coma.




Post natal complications such as 
kernicterus, meningitis and head 
trauma.
Methods:
For each index case enrolled in the 
work, the following set of assessments 
and investigations was carried out:
Full clinical history.1. 
Three generations pedigree 2. 
analysis.
Thorough clinical examination.3. 
Intelligent Quotient (IQ) 4. 
assessment.5
Karyotype if indicated.5. 
Biochemical evaluation, including 6. 
calcium, glucose, liver and kidney 
function tests.
Blood gases, and electrolytes 7. 
and pH.
Ferric chloride test.8. 6
Quantitive determination of amino 9. 
acids was done by different 
methods:
a)Amino acid analyzer Sykam 
(S-433): based on the ninhydrin 
post - column derivatisation 
method.
b)Extended metabolic screen.
c)Quantitative determination of 
phenylalanine alone by quantase 
neonatal phenylalanine screening 
(Bio-Rad Laboratories, UK).
RESULTS                                                                       
The total number of cases attending 
the outpatient clinic during the period 
of study were 1343 index cases, among 
them 50 cases (3.72%) were suspected 
of having inborn errors of amino acids 
and fulfilling the inclusion criteria, 20 
cases (40%) of them have confirmed 
positive inborn errors of amino acid 
metabolism.
The results of the present study could 
be summarized in the following 
points:
The chronological age of the 
studied index cases ranged from 
5 days to  11 years (Mean 49.11 
months±37.83months). Index cases 
were 23 (46%) males ranging in age 
from 9 months to 10 years (Mean 43.87 
months±26.65 months) and 27 (54%) 
females ranging in age from 5 days to 
11 years (Mean 53.58 months±45.28 
months).
The parental birth origin in Lower Egypt 
was higher (69.5%) than that in Upper 
Egypt (30.4%). A positive consanguinity 
was found in 32 families (69.56%), 
where 56.52% of the parents were 1st 
cousins and 13.04% were 2nd cousins, 
while 14 families (30.43%) were not 
consanguineous. 20 families out of 46 
families (43.5%) had positive family 
history of affected relatives, among 
them 15 families (32.6%) had other 
affected siblings and 5 families (10.9%) 
had aunt or uncle affected, whereas 26 
families (56.5%) had negative family 
history. 
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The clinical characteristics of the 
studied cases are summarized in 
(Table 1):
Presenting complaint: the most 1. 
common presenting complaint was 
mental retardation with convulsions 
(42%), followed by mental 
retardation alone (20%) and mental 
retardation with hyperactivity 
(20%). 
Course: it was progressive in 36% 2. 
of cases, while it was stationary or 
regressive with treatment in 28% of 
cases in each. Rapid deterioration 
and death occurred in 4% of cases. 
Anthropometric examination: 3. 
micro-cephally was found in 10% 
of cases, while short stature was 
found in 12%.
Neurological features: hypertonia 4. 
and hyperreflexia was found in 
50% of cases, while only 4% were 
presented with hypotonia and 
hyporeflexia. Convulsions were 
found in 46% of cases. Mental 
retardation was recorded in 88% 
of cases, of which severe mental 
retardation was recorded in 34% of 
cases.
Hepatomegaly was found in only 5. 
2% of cases. 
Dermatological features: fair 6. 
complexion was found in 28% 
of cases, 4% of them had also 
eczema. 
Associated anomalies were found 7. 
in 30% of cases, among them eye 
anomalies were the most common 
(8%).
Table 1: Clinical Characteristics of the Studied Cases.
Presenting features Number %
Presenting complain*
Mental retardation 10 20
Mental retardation with 
convulsions 21 42
Mental retardation with 
hyperactivity 10 20
Convulsions 1 2
Abnormal odor of urine 1 2
Discoloration of urine 1 2
Family history of unexplained 
neonatal deaths 3 6
Hepatomegaly 1 2




Regression with treatment 14 28
Rapid deterioration and death 2 4
Anthropometric examination
Microcephaly 5 10









Mental retardation 44 88
Mild (IQ: 52-67) 7 14
Moderate (IQ: 36-51) 15 30
Severe (IQ: 20 - 35) 17 34
Profound (IQ<20) 5 10
Hepatomegally 1 2
Dermatological features
Fair complexion 14 28
Eczema 2 4
Associated anomalies 15 30
Gastro-esophageal reflux 1 2
Meningocele 1 2
Undescended testicles 1 2
Bilateral hip dislocation 1 2
Umbilical hernia 2 4
Rocker bottom heel 1 2
Hemangioma on the abdomen 1 2
Mitral valve regurge 1 2
Postaxial polydactyly 1 2
Tongue tie 1 2
Eye anomalies 4 8
Optic atrophy 2 4
Optic atrophy with squint 1 2
Nystagmus 1 2
* Six cases presented with normal mentality.
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Out of the 50 index cases suspected to 
have metabolic disease, 20 cases (40%) 
had amino-acido-pathies, among them 
15 cases (30%) had PKU, one case 
(2%) had alkaptonuria, one case (2%) 
had citrullinemia, one case (2%) had 
nonketotic hyperglycinemia, and one 
case (2%) had trimethylaminuria (Fish 
odor syndrome) (Table 2).
Table 2: Aminoacidopathies detected over the 
period of this study.
Amino-acido-pathy No of cases %
Phenylketonuria 15 30
Urea cycle defects 
(Citrullinemia) 1 2
Hyperglycinemia 1 2




(Fish odor syndrome) 1 2
Total 20 40
The Prevalence of amino-acido-
pathies detected over the period of this 
study among 1343 cases attending the 
Genetics Clinic was 20 cases (1.5%). 
Phenylketonuria represented 1.11%, 
while the remaining diagnosed cases 
represented 0.07% for each table (2).
Concerning the confirmed 20 cases, it 
was found that their age ranged from 
5 days to 11 years with a mean of 
54.75±33.09 months. Their maximum 
age incidence was early childhood 
(60%). Both sexes were equally 
affected. Con-sanguinity was present 
in 65% of cases, of which 50% were 
first cousins, and 15% were second 
cousins. The family history of similarly 
affected cases was 30% of which 25% 
had other sibs affected. 
The main presenting complain among 
examined cases was mental retardation 
with convulsions and mental retardation 
with hyperactivity (40%) in each. 
Clinical examination revealed micro-
cephaly in 15% of cases, hypertonia 
and hyperreflexia in 35% of cases in 
each, convulsions in 40% and mental 
retardation in 85% of cases, of which 
severe mental retardation present 
in 55%. Associated anomalies were 
present in 35% of cases, among them 
eye anomalies were the most common 
in form of optic atrophy in 5% and 
nystagmus in 5%.
Case report of index case no 43:
Male patient, 4 years years old, the 2nd 
offspring of consanguineous parents, 
with negative family history (Figures 1, 
2, 3) & parental birth origin was from 
Lower Egypt. His mother complained 
of darkening of the urine since birth to 
an almost black color when it was left 
standing exposed to air with stationary 
course.
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A)                                   B)
Fig. 3:a- Male patient no(43)with Alkaptonuria
           b- Black colored urine of the patient.
Physical examination: Revealed a 
healthy child with normal mentality, 
growth and development, associated 
with umbilical hernia. There was no 
abnormal pigmentation of the sclera, 
conjunctiva, and cornea or ear cartilage. 
Joint examination was normal. 
Investigations:
Ferric chloride test: slight • 
bluish discoloration which then 
disappeared. 
Fig. 1: Family pedigree of index case no (43).
Fig. 2: Curve of amino acids separation of case (43).
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Kidney function tests were normal. • 
Skeletal survey showed no • 
degenerative changes.
Echocardiography: • 
       revealed no abnormalities.
Amino acids concentrations were • 
normal as detected by amino acid 
analyzer figure (2).
He was on vitamin C, currently, • 
the patient is asymptomatic and is 
under follow up every six months 
in the outpatient clinic. 
Diagnosis: Alkaptonuria.
Case report of index case no 35:
Female patient, 5 days old, the 4th 
offspring of consanguineous parents 
with positive family history (3 previous 
neonatal deaths) (Figures 4 & 5). Parental 
birth origin was from Lower Egypt. She 
was well until the sixth day, when she 
developed poor suckling, convulsions, 
difficulty in respiration and episodes of 
cyanosis. She was admitted to Neonatal 
Intensive Care Unit and died at age of 
15 days. Blood gases and pH revealed 
metabolic acidosis.
Fig. 5: A female patient no (35) with maple 
syrup urine disease (Poor suckling, convulsions 
and difficult breathing).
Amino-acids concentrations determined 
by amino-acid analyzer revealed raised 
levels of leucine, isoleucine and valine 
(Figure 6).
Diagnosis: Maple syrup urine disease.
Case report of index case no 18:
Female patient aged 11 years, the 2nd 
offspring of consanguineous parents 
with positive family history of affected 
2 male sibs and the index mother 
(Figures 7 & 8). Parental birth origin 
was from Upper Egypt. Her mother 
Fig. 4: Family pedigree of index case no. (35).
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Fig. 6: Curve of amino acids separation of case (35).
Fig. 7: Family pedigree of index case no 18.
noticed a fishy smell in urine, sweat and 
breath at the age of 4 years, stationary 
in course. The patient had normal 
mentality, growth and development 
without neurological abnormalities. She 
had anxiety and social isolation. 





Extended metabolic screening: revealed 
no abnormalities in amino-acids, 
organic acids and fatty acids. Plasma 
ammonia, lactate, pyruvate were 
normal. Echocardiography: revealed 
mild mitral regurge (Rheumatic mitral 
valve).
Diagnosis: Most probably fish odor 
syndrome (Trimethylaminuria).
Case report of index case no 46:
Female patient aged 32/12 years 
old. She is the 1st offspring of 
consanguineous parents, with negative 
family history (Figure 9). Parents’ birth 
origin was from Upper Egypt. Her 
mother complained of developmental 
delay of her daughter and convulsions 
not responding to anti-convulsants.
By examination, she had delayed 
physical and mental milestones, 
hypertonia with hyperreflexia and she 
had microcephaly, fair skin and hair, 
hypertelorism, depressed nasal bridge 
and severe mental retardation.
Investigations showed normal ferric 
chloride test for urine. Blood pH and 
blood ammonia were normal. MRI of 
brain showed brain atrophy and crescent 
like arachnoid cyst in left temporal pole. 
Slit lamp examination revealed normal 
fundus. Amino acids concentrations 
determined by amino acid analyzer 




Case report of index case no. 25:
Male patient aged 4.5 years. He is the 
2nd offspring of consanguineous parents 
with positive family history (His brother 
was not examined) (Figure 11). Parental 
birth origin was from Lower Egypt. 
His mother complained of develop-
mental delay, attacks of drowsiness, 
and tonic clonic convulsions of her 
son, progressive in course. During the 
study period the mother delivered a 
female baby who was also investigated. 
He had delayed mental and physical 
Fig. 9: Family pedigree of index case no (46).
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milestones of development, hypertonia, 
hyperreflexia and severe mental 
retardation. There was mild elevation 
of blood ammonia (320 μmol/L), 
while blood pH, lactate and pyruvate 
were normal. MRI of the brain showed 
hypoplasia of cerebellum. 
Extended metabolic screen revealed 
high level of citrulline 730 μmol/L 
(Normal:5–95 μmol/l). The female 
infant (Two months) was also 
investigated by extended metabolic 
screen and showed no abnormalities 
in amino acids, organic acids or fatty 
acids.
Diagnosis: Urea cycle defect 
(Citrullinemia). 
PKU cases:
PKU cases were classified into classical 
type [11 cases (73.3%)] with blood 
phenylalanine>1200 mmol/l and 
atypical type [4 cases (26.7%)] with 
blood phenylalanine<1200 mmol/l. 
Their blood phenylalanine ranged 
from 810-1673 mmol/l with the mean 
of 880.58 mmol/l (Normal: 41–86 
μmol/L). FeCl3 test was dark green in 
all PKU cases.
Fig. 10: Curve of amino acids separation of case (46)
Fig. 11: Family pedigree of index case no (25).
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The maximum age incidence at time 
of examination was early childhood 
[9 cases (60%)], with approximately 
equal sex distribution. Consanguinity 
was found in 8 families (66.67%) and 
first cousins were the most prevalent 
(58.33%). Four families (33.33%) 
had positive family history of affected 
members.
The main clinical findings among 
our cases included mental retardation 
in 100%, hyperactivity in 53.33%, 
convulsions in 40%, microcephaly in 
13.33%, hypo pigmentation in 86.7%, 
and associated anomalies in 26.7%, in 
the form of meningocele in 1 patient, 
bilateral optic atrophy in1 patient, 
gastroesophageal reflux in 1 patient 
and undescended testes in1 patient.
(Figure 12a & b) shows case no. 9, a 6 
years old male with PKU.
Fig. 12a: Case no. 9 a 6 years old male with 
PKU. He is the 1st off spring of consanguineous 
parents (1st cousins), and presented with severe 
mental retardation, convulsions, hyperactivity, 
and convulsions since birth. EEG detected 
multiple epileptogenic activities with tendency 
for secondary generalization.
Fig. 12b: Curve of plasma amino acids separation by amino acid analyzer of case no. 9. The plasma 
phenylalanine level was 1673.24 mmol/L (Normal: 41–86 μmol/L).
DISCUSSION                                                                      
Inborn errors of metabolism should be 
considered in severely ill neonates with 
lethargy, poor feeding, convulsions, 
coma and death in the neonatal period 
especially if there is positive sib death 
or consanguineous marriage. Also, 
inborn errors of metabolism should be 
suspected in children with unexplained 
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mental retardation, developmental 
delay or convulsions.7
There are two main problems in 
detecting inborn errors of metabolism:
Symptoms are nonspecific and often 1. 
similar to those of sick neonates, 
therefore, only a small number of 
these diseases will be diagnosed 
from typical clinical picture alone 
and we can rarely target the specific 
investigation required for diagnosis 
of the offending disease.
Investigations are complex and 2. 
expensive.8
In our study, out of 1343 cases attending 
the outpatient clinics, 50 cases were 
suspected to have metabolic disease, 
20 cases of them (40%) proved to have 
amino-acido-pathies (Representing 
1.5% of the total). Out of the 20 cases of 
amino-acido-pathies identified, 15 cases 
(30%) had PKU, one case (2%) had 
hyperglycinemia, one case (2%)  had 
MSUD, one case (2%) had alkaptonuria, 
one case (2%) had citrullinemia  and 
one case (2%) had trimethylaminuria 
(Fish odor syndrome).
On the other hand, a greater percentage 
(10%) of cases with amino acid defects 
were recorded by another genetic study 
done in Egypt on 100 mental retarded 
patients by Abdel-Meguid.9 Also 
Temtamy et al. recorded disturbances 
of amino acid metabolism in 4.2% of 
mentally retarded cases in Egyptian 
children.10
Shawky et al. reported that 51 cases 
out of 450 studied mental retarded 
cases (11.32%) have confirmed positive 
inborn errors of amino acid metabolism. 
Forty cases (78%) have PKU, four cases 
(7.84%) had  generalized non-specific 
amino aciduria, two cases (3.92%) 
had NKH, two cases (3.92%) had 
hyperprolinemia, two cases (3.92%) 
had histidinemia and one case (1.96%) 
had homocystinuria.11
El-Sobky and El-Sayed studied 231 
cases (44 neonate and 187 children) 
with different symptoms suggesting 
inborn errors of metabolism. Abnormal 
results were found in 26 cases (31.3%) 
which included 13 cases (10.4%) with 
amino-acido-pathies, two cases (4.55%) 
with fatty acid oxidation defects, 8 
cases (14.7%) with organic acidemia 
and three cases (1.6%) with cystic 
fibrosis, congenital adrenal hyperplasia 
and congenital hypothyroidism.8
As regards the age and sex distribution 
of the suspected index cases fulfilling 
the inclusion criteria; their ages 
ranged from 5 days to 11 years with a 
mean of (53.58+45.28 months). Their 
maximum age incidence was early 
childhood representing 25 cases, 50%, 
similarly the maximum age incidence 
was early childhood in confirmed 
cases representing (12 cases, 60%). 
Both sexes were equally distributed in 
both suspected and confirmed cases. 
Most inborn errors of metabolism are 
inherited in an autosomal recessive 
manner. Both sexes are affected equally 
in autosomal recessive conditions.12
In the present study, the age of onset 
of amino acid disorders was variable. 
Alkaptonuria and MSUD presented 
at birth, trimethylaminuria in early 
childhood citrullinemia PKU in 
early infancy, while non-ketotic 




Disorders of amino acid metabolism 
can present at any age but are not 
usually symptomatic at birth or in the 
first day of life. Disorders with acute 
presentation often presents at time of 
protein catabolism e.g. in the neonatal 
period (Metabolic transition, delayed 
food in-take), late infancy (Change 
to protein  rich meals with greater 
intervals; common infections with 
fever, vomiting and reduced food in-
take) or puberty (Change in growth 
rate, psychosocial factors).13 Ozand 
and Gascon revealed that different 
phenotypic expression with different 
ages was observed in inborn errors of 
metabolism even among members of 
the same family, however, the neonatal 
onset is invariably lethal.14
In the present study, Lower Egypt had 
the highest incidence as parental birth 
origin (69.5%). This epidemiologic 
information allows appropriate 
screening and counseling. The same 
result was also reported in a study done 
by Shawky et al.11
The overall recorded consanguinity 
rate among the suspected cases in our 
study was 69.56% of which 56.52% 
was first cousins while second cousins 
consanguinity represented 13.04%. On 
the other hand, consanguinity among 
the confirmed cases in our study was 
65% of which 50% was first cousins.
Consanguinity rate may reach up to 28% 
in Egypt which helps to accumulate 
deleterious genes in families.15 
Also, Abdel-Salam et al. found a 
consanguinity rate of 36.2% in rural 
areas and of 20.37% in urban  areas 
in Egypt.16 Consanguinity is of special 
importance in genetic counseling of 
autosomal recessive disorders.
Shawky et al. reported that consanguinity 
rate of mentally retarded patients of the 
selective screening program for mentally 
retarded cases were 74.5% and 52.9% 
had first cousins consanguinity.11
The family history of similarly affected 
cases with suspected metabolic  disorder 
in our study was recorded in 43.5% of 
our index families of which 32.6% had 
an-other sibling affected and 10.9% 
had an aunt or uncle affected. While 
the family history of confirmed cases 
was 30%, of which 25% had other sibs 
affected.
Shawky et al. reported that family 
history of mental subnormality of 
similar disorders among the selective 
screening program was 37 %.11
In this study, one index case (2% of the 50 
index cases suspected to have metabolic 
disease, and 0.07% of the 1343 cases 
attending the clinic during the period 
of the study) had trimethylaminuria, 
resulting in fishy smell of urine, sweat 
and breath as noticed by the mother at 
the age of 4 years. Family history was 
positive for her mother and two affected 
sibs. 
Extended metabolic screen showed no 
abnormalities in amino acids or organic 
acids in this syndrome. Mitchell and 
Smith reported that over 200 cases 
of the disease have been described 
on a world wide basis.17 Lee et al. 
found that the condition could affect 
infants, children and adults and it was 
confirmed to be associated with the 
excretion of excessive amount of trim 
ethylamine18, while Chalmers showed 
that the disorder was present from 
birth but became apparent as foods 
containing high amounts of choline or 
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trimethylamine N oxide from marine 
(Sea or salt water) fish were introduced 
into the diet.19 The cause of the disease 
is a lack of the trimethylamine oxidase 
enzyme in liver. 
Normally this enzyme oxidizes 
trimethylamine to trimethylamine oxide 
which is odorless and is excreted in 
urine. This metabolic defect ca-uses 
massive excretion of trimethylamine 
in urine.20 Phillips et al. found that 
the flavin mono-oxygenase (FMO) 
family of enzymes was responsible for 
trimethyl-amine oxidation.21 The final 
diagnosis should be made by detection 
of urinary trimethylamine greater 
than 18 μmol/mmol creatinine by gas 
chromatography.22
In the present study, one index case 
(2% of the 50 index cases suspected 
to have metabolic disease, and 
0.07% of the 1343 cases attending 
the clinic during the period of the 
study), had citrullinemia presenting 
with convulsions,  drowsiness, mental 
retardation and a similar family history 
of an affected sister. He had a plasma 
ammonia concentration of 320 mmg/L 
(Normal: 80-110 μmol/L) with elevated 
citrulline 730 μmol/L by ex-tended 
metabolic screen. This was consistent 
with the reported gradual onset of 
clinical symptoms of this disorder, in the 
form of mental retardation, attacks of 
drowsiness and tonic clonic convulsions 
at the age of two years, when the 
diagnosis was missed in infancy.23
Van-Buggenhout et al. reported that 
among 306 patients screened for 
metabolic disorder, two cases (0.6%) 
were proved to have citrullinemia.24
In our study, one female patient of 
consanguineous parents (2% of the 
50 index  cases  suspected  to  have 
metabolic disease, and 0.07% of the 1343 
cases attending the clinic during  the 
period of the study), with a percentage 
of 0.07% of the 1343 attending cases 
during the period of the study, had 
MSUD disease. She presented with 
poor suckling, convulsions, difficulty 
in respiration, episodes of cyanosis and 
died at the age of 15 days.
Sobky and El-Sayed reported that 
among 231 cases with different 
symptoms suggesting in born errors of 
metabolism, 2 cases (0.9%) with MSUD 
were detected.8
In our study, one index male patient 
(2% of the 50 index cases suspected 
to have metabolic disease, and 0.07% 
of the 1343 cases attending the clinic 
during the period of the study) with 
a percentage of 0.07% of the 1343 
attending cases during the period of 
study, had alkaptonuria. The child was 4 
years old of consanguineous parents. His 
mother noticed darkening of the urine to 
almost black since birth when exposed 
to air, stationary in course. Amino 
acid profiles were normal as detected 
by amino acid analyzer. Ozalp et al. 
reported that alkaptonuria represents 
0.11% of the total selective cases in 
Turkey.25 While Kaur et al. showed that 
Alkaptonuria represents 0.51% of the 
selective cases in North India 3. In the 
literature, more than 126 patients with 
alkaptonuria have been reported from 
Czechoslovakia, 108 from Germany 
and 90 from United States. In countries 
of Middle East, the disease  was  first 
reported from Lebanon in 1958 and from 
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Sudan in 1965, two adult patients from 
Saudi Arabia and one from Yemen.26
In our study, one female patient (2% of 
the 50 index cases suspected to have 
metabolic disease, and 0.07% of the 
1343 cases attending the clinic during 
the period of the study %) was diagnosed 
as NKH. The patient was 3.2/12years 
old, of consanguineous parents. She 
had been well with normal development 
up to one year of age, and then there 
was rapid deterioration in mental and 
motor milestones of development, 
and convulsions not responding to 
anticonvulsant drugs. On referral she 
was found to have lower limb spasticity 
with hypertonia  and hyperreflexia. MRI 
showed periventricular leukomalacia 
with left temporal arachnoid cyst. 
Amino acid concentrations determined 
by amino acid analyzer showed raised 
level of plasma glycine (709.73 μmol/L; 
normal range: 1–15 μmol/L). 
Shawky et al. reported that among 450 
cases of mentally retarded patients two 
cases (0.4%) of NKH were detected.11 
Wraith et al. reported that infantile 
NKH has been described in several 
children who had normal growth and 
development until at least six months of 
age, then developed lethargy, refusal to 
feed, profound hypotonia, seizures and 
moderate mental retardation.27 This is 
in accordance with our case as regards 
the age of onset, moderate mental 
retardation, seizures, while hypertonia 
was a constant feature of our reported 
case. 
PKU was the most common in-born 
error of amino acid metabolism among 
our cases (30%), with a percentage 
of 1.1% of the 1343 attending cases 
during the period of study. The blood 
phenylalanine level ranged from 810-
1673. 29 μmol/L. Shawky et al. reported 
that PKU was the most common inborn 
error of amino acid metabolism, it 
represented 78% of disturbances of 
amino acid and 8.9% of the 450 studied 
mentally retarded cases.11
In the present study, PKU cases were 
classified into classic type (73.3%) with 
blood phenylalanine>1200 μmol/L 
and atypical type (26.7%) with blood 
phenylalanine<1200 μmol/l. Shawky 
et al. reported that PKU cases can be 
classified into: classic type (90%), 
atypical type (7.5%) and malignant 
type (2.5%) 11. The main clinical 
finding among our PKU cases included 
hypopigmentation (86.7%), mental 
retardation (100%), seizures (33.33%), 
hyper-activity (53.33%) and micro-
cephaly (13.33%). Shawky et al. (2001) 
showed that the main clinical finding 
included hypopigmentation (100%), 
microcephaly (37.5%), hyperactivity 
(90%), seizures (25%) and abnormal 
EEG (42.5%).11
RECOMMENDATIONS                                       
The remaining cases with unexplained 
mental retardation need further follow 
up and further investigations in order to 
reach a specific diagnosis to guide their 
families in prenatal diagnosis.
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